Cancer-related Breakthrough Pain

2. Auflage 2012
ISBN: 978-0-19-965697-4
Verlag: OUP Oxford

Buch, Englisch, 128 Seiten, Format (B × H): 141 mm x 196 mm, Gewicht: 163 g

Reihe: OXFORD PAIN MANAGEMENT LIBRARY SERIES OPML P

Malignant episodic (or 'breakthrough') pain is a common feature of cancer pain that can have a negative impact on quality of life for both the patient and carer. It is characterized by a periodic increase in pain over background cancer pain and can be both severe in intensity and rapid in onset. Some patients who experience breakthrough pain are unresponsive to treatment and can pose a clinical challenge for physicians.

This volume contains chapters detailing strategies for the assessment, management and treatment of breakthrough pain. The use of opioids for the treatment of breakthrough pain is thoroughly explored, with material covering oral, nasal and other routes for opioid administration. Furthermore, the book includes chapters on non-opioid pharmacological treatments, as well as non-pharmacological interventions.

New additions to the second edition include a revised chapter on the general management of breakthrough pain and an up-to-date section on the latest data on intranasal fentanyl products. These updates ensure that Cancer-related Breakthrough Pain continues to be an invaluable resource for specialists and trainees in the field of pain management, as well as being a quick reference guide for GPs, specialist nurses, and other medical professionals.

Zielgruppe

This pocketbook will be essential reading for all consultants, specialist nurses, trainees, GPs, and other medical practitioners involved in the management of cancer pain.

Autoren/Hrsg.

Davies, Andrew

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete AINS Schmerzmedizin & Schmerztherapie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pflege Fachpflege

Inhaltsverzeichnis

1: Introduction
2: Clinical features
3: Assessment
4: General principles of management
5: Oral opioid drugs
6: Oral transmucosal drugs
7: Opioid drugs via other routes
8: Non-opioid drugs
9: Other theraputic interventions

Über Autor(innen)

Davies, Andrew
Andrew Davies, Consultant in Palliative Medicine, St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, UK

Dr Andrew Davies trained at St. George's Hospital Medical School (University of London), and after completing general medical training (MRCP) specialised initially in Clinical Oncology, and then in Palliative Medicine. He has been a Consultant in Palliative Medicine for over 10 years, and has previously been Senior Lecturer in Palliative Medicine at University of Bristol, and more recently Consultant in Palliative Medicine at Royal Marsden Hospital (Sutton). Dr
Davies has a particular interest in the management of breakthrough / incident pain (e.g. movement-related pain), neuropathic pain, dry mouth and other oral problems.